AVAMYS

Following these instructions should ensure that patients always get the full dose of Avamys.

Intranasal therapies

As with many chronic conditions, poor adherence is a significant issue in the management of allergic and non-allergic rhinitis 12

Watch the video and hear Dr Jorge Maspero discuss factors such as adherence and usage technique that can influence the effectiveness of intranasal therapy.

Device-related attributes

Many factors can affect the patient acceptability of nasal spray devices, and thereby patient adherence  34

Watch the video and hear Dr Anahi Yanez discuss what the key issues are, and how the Avamys device can help.

Avamys – an innovative device

The Avamys device has several features that may affect patient preference, including ease of use, consistent dosing and a fine, gentle mist.

Watch the video to find out why patients prefer it over mometasone furoate nasal spray 5

Intranasal spray device comparison

The Avamys device produces a fine, gentle spray designed to minimise unwanted effects such as drip down the nose or throat, irritation and after-taste 5

Watch the video and see the differences for yourself.

Allergic rhinitis: more than just a sneeze

Allergic rhinitis can have a serious impact on patient’s lives, particularly through disruptions to sleep 6

Watch the video and hear the full spectrum of its effects on patients’ lives, including the estimated impact of indirect medical costs.

Differential diagnosis of allergic rhinitis

The symptoms of allergic rhinitis can also be seen in variety of infectious and non-infections conditions   7

Watch the video and explore a typical patient case, the alternative diagnoses and the key points of differentiation for physicians.

Allergic rhinitis and asthma

An estimated 40% of allergic rhinitis patients also suffer from asthma 8

Watch the video to discover the implications, and why a combined treatment strategy is recommended   9